title: Effect of atenolol and labetalol on serum lipids.
abstract: Adverse alterations in lipid profile suggesting higher atherogenicity were observed following 12 weeks treatment with atenolol in patients of hypertension. No significant alterations in lipid profile were observed with labetalol therapy.
authors.affiliation: Dept. of Med & Biochem, Medical College, Rohtak.
authors.forename: S B
authors.initials: SB
authors.lastname: Siwach
authors.forename: S S
authors.initials: SS
authors.lastname: Dahiya
authors.forename: S
authors.initials: S
authors.lastname: Seth
authors.forename: R K
authors.initials: RK
authors.lastname: Seth
authors.forename: D
authors.initials: D
authors.lastname: Sharma
mesh_terms: D001262:Atenolol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects*; D008055:Lipids / Q000097:blood*; D008297:Male
chemical_list: D008055:Lipids; D001262:Atenolol; D007741:Labetalol